We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » MYLAN TO BUY KING IN $4 BILLION STOCK TRANSACTION
MYLAN TO BUY KING IN $4 BILLION STOCK TRANSACTION
July 26, 2004
Generic heavyweight Mylan Laboratories plans to acquire drugmaker King Pharmaceuticals in a $4 billion stock swap that will give Mylan access to four of King’s brand products, which generate annual sales of more than $100 million each.